AZ sells EU rights to Seloken, Logimax to Recordati

22nd May 2017 Uncategorised 0

AstraZeneca has sold European rights to its metoprolol-containing cardiovascular drugs to Italian drugmaker Recordati for $300 million.

More: AZ sells EU rights to Seloken, Logimax to Recordati
Source: News